Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
A marker strongly associated with outcome (or disease) is often assumed to be effective for classifying persons according to their current or future outcome. However, for this assumption to be true, the associated odds ratio must be of a magnitude rarely seen in epidemiologic studies. In this paper, an illustration of the relation between odds ratios and receiver operating characteristic curves shows, for example, that a marker with an odds ratio of as high as 3 is in fact a very poor classification tool. If a marker identifies 10% of controls as positive (false positives) and has an odds ratio of 3, then it will correctly identify only 25% of cases as positive (true positives). The authors illustrate that a single measure of association such as an odds ratio does not meaningfully describe a marker's ability to classify subjects. Appropriate statistical methods for assessing and reporting the classification power of a marker are described. In addition, the serious pitfalls of using more traditional methods based on parameters in logistic regression models are illustrated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, for diagnostic, prognostic, or screening markers in epidemiologic studies, the limited magnitude of the OR considered meaningful (i.e., about or >70) is rarely discussed (36).”
From Misrepresentation and distortion of research in biomedical literature (2018) · cites this paper as [36]
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“Examples include the Framingham risk score for cardiovascular events (2) and the Gail model risk score for breast cancer (3).”
BackgroundA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“Examples from other popular journals are Ridker et al. ( 11 ), Zhang et al. (12), Liou et al. (13), and Hogue et al. (14).”
BackgroundGail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
The Statistical Evaluation of Medical Tests for Classification and Prediction
(2005) · Technometrics · doi:10.1198/tech.2005.s278 · Cited by 1,899
Self-citationCarney, P. A., Miglioretti, D. L., Yankaskas, B. C., Kerlikowske, K., Rosenberg, R., Rutter, C. M., Geller, B. M., Abraham, L. A., Taplin, S. H., Dignan, M., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00008 · Cited by 1,142
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data
WIEAND, S., GAIL, M. H., JAMES, B. R., & JAMES, K. L. (1989) · Biometrika · doi:10.1093/biomet/76.3.585 · Cited by 355
Cited by
Items 801–900 of 1,000
Snowden, J. M., Tilden, E. L., & Odden, M. C. (2018) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12868 · Cited by 11
Evaluating the Prognostic Value of New Cardiovascular Biomarkers
Wood, A., & Greenland, P. (2009) · Disease Markers · doi:10.1155/2009/412947 · Cited by 11
How close are we to customizing chemotherapy in early non-small cell lung cancer?
Ioannidis, G., Georgoulias, V., & Souglakos, J. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011409973 · Cited by 11
Definitions and mechanisms of the metabolic syndrome
Meigs, J. B. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.med.0000216957.13633.58 · Cited by 11
Diakowska, D., Krzystek‐Korpacka, M., Lewandowski, A., Grabowski, K., & Diakowski, W. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.03.014 · Cited by 11
Harder, T., Seidel, J., Eckmanns, T., Weiß, B., & Haller, S. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014986 · Cited by 11
The Search for Diagnostic Markers in Sepsis: Many Miles Yet to Go
Calfee, C. S., & Pugin, J. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0854ed · Cited by 11
Cheung, S., Ho, J. C.-Y., Leung, K. L., Chen, X., Fong, D., So, S. K., & Fan, S. T. (2005) · Neoplasia · doi:10.1593/neo.04472 · Cited by 11
Frostadottir, D., Perez, R., & Dahlin, L. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-57757-w · Cited by 10
Hassan, M., Öberg, J., Wemrell, M., Vicente, R. P., Lindström, M., & Merlo, J. (2024) · International Journal for Equity in Health · doi:10.1186/s12939-024-02291-4 · Cited by 10
COMPARING RISK SCORING SYSTEMS BEYOND THE ROC PARADIGM IN SURVIVAL ANALYSIS
Uno, H., Tian, L., Cai, T., Tian, L., Cai, T., Kohane, I. S., & Wei, L. J. (2009) · Collection of Biostatistics Research Archive · Cited by 10
Early Prediction of Cardiovascular Disease in Kidney Transplant Recipients
Bilancio, G., Celano, M., Cozza, V., Zingone, F., Palladino, G., & Círillo, M. (2017) · Transplantation Proceedings · doi:10.1016/j.transproceed.2017.09.005 · Cited by 10
Munabi, I. G., Luboga, S. A., & Mirembe, F. M. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1183-z · Cited by 10
Biomarkers for Coronary Heart Disease Clinical Risk Prediction: A Critical Appraisal
Wilkins, J. T., & Lloyd‐Jones, D. M. (2010) · Preventive Cardiology · doi:10.1111/j.1751-7141.2010.00081.x · Cited by 10
Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs
Baker, S. G., & Kramer, B. S. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0092 · Cited by 10
Staats, M. L. P., Kivisto, A. J., & Connell, R. (2020) · International Journal of Law and Psychiatry · doi:10.1016/j.ijlp.2020.101654 · Cited by 10
Genetics and the Individualized Prediction of Fracture
Nguyen, T. V., & Eisman, J. A. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-012-0113-4 · Cited by 10
Hollar, D. (2009) · Genetica · doi:10.1007/s10709-009-9369-8 · Cited by 10
Zhu, H., & Shi, C. (2007) · Ophthalmic Research · doi:10.1159/000108123 · Cited by 10
Charpentier, S., Cournot, M., Lauque, D., Girardi, C., Bounes, V., Elbaz, M., & Ducassé, J.-L. (2010) · Emergency Medicine Journal · doi:10.1136/emj.2010.094284 · Cited by 10
Chapter 1 Clinical validation of biomarkers for predicting risk
Levinson, S. S. (2009) · Advances in clinical chemistry · doi:10.1016/s0065-2423(09)48001-6 · Cited by 10
Marrie, R. A. (2007) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 10
Use of biomarkers to develop treatment strategies for atherosclerosis
Crandall, M. A., & Corson, M. A. (2008) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-008-0051-8 · Cited by 10
Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis
Newton, C. A., Thenappan, A., Liu, G. Y., Yazbeck, L., Lee, C. T., Pugashetti, J. V., Wang, J. M., White, E., Flaherty, K. R., Belloli, E. A., et al. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202501-0317oc · Cited by 9
Assessing diagnostic accuracy improvement for survival or competing‐risk censored outcomes
Shi, H., Cheng, Y., & Li, J. (2014) · Canadian Journal of Statistics · doi:10.1002/cjs.11205 · Cited by 9
Ning, H., Kershaw, K. N., Allen, N. B., Wilkins, J. T., & Lloyd‐Jones, D. M. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100222 · Cited by 9
Iqbal, M., Kamarullah, W., Achmad, C., Karwiky, G., & Akbar, M. R. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102241 · Cited by 9
Gene-environment interactions in occupational asthma
Kauffmann, F., Castro-Giner, F., Smit, L. A. M., Nadif, R., & Kogevinas, M. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8556-9_12 · Cited by 9
Turner, A. R., Kader, A. K., & Xu, J. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02522.x · Cited by 9
Roelen, C. A. M., Bültmann, U., Groothoff, J. W., Twisk, J. W. R., & Heymans, M. W. (2015) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-015-1032-3 · Cited by 9
Mannan, H. R., Stevenson, C., Peeters, A., Walls, H., & McNeil, J. J. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-39 · Cited by 9
Tian, L., Cai, T., & Wei, L. (2008) · Biometrics · doi:10.1111/j.1541-0420.2008.01125.x · Cited by 9
Personalized medicine and atrial fibrillation: will it ever happen?
Lubitz, S. A., & Ellinor, P. T. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-155 · Cited by 10
Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden
Bjerkeli, P. J., Mulinari, S., Zettermark, S., & Merlo, J. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2361-9 · Cited by 9
Ghith, N., Frølich, A., & Merlo, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189050 · Cited by 9
Hospital differences in mortality rates after hip fracture surgery in Denmark
Kristensen, P. K., Merlo, J., Ghith, N., Leckie, G., & Johnsen, S. P. (2019) · Clinical Epidemiology · doi:10.2147/clep.s213898 · Cited by 9
Developing Biomarker Panels to Predict Progression of Acute Kidney Injury After Cardiac Surgery
Kerr, K. F., Morenz, E. R., Roth, J., Thiessen‐Philbrook, H., Coca, S. G., & Parikh, C. R. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.08.017 · Cited by 9
Non-national clients in Belgian substance use treatment
Kock, C. D., Blomme, E., & Antoine, J. (2020) · Drugs and Alcohol Today · doi:10.1108/dat-12-2019-0049 · Cited by 9
Duran-Chávez, J., Grandi, C., Rodrigues, L. D. S., de Freitas, S. F., Cardoso, V. C., & Cavalli, R. D. C. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.03.026 · Cited by 9
Gating of a novel brain potential is associated with perceptual anomalies in bipolar disorder
Patterson, J. V., Sandman, C. A., Jin, Y., Kemp, A. S., Potkin, S. G., & Bunney, W. E. (2013) · Bipolar Disorders · doi:10.1111/bdi.12048 · Cited by 10
Prognostic Factors for Recurrences in Neck Pain Patients Up to 1 Year After Chiropractic Care
Langenfeld, A., Humphreys, B. K., Swanenburg, J., & Peterson, C. K. (2015) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2015.06.014 · Cited by 9
Predicting Time to Subsequent Pregnancy
Gold, R. B., Connell, F. A., Heagerty, P. J., Cummings, P., Bezruchka, S., Davis, R. L., & Cawthon, M. L. (2005) · Maternal and Child Health Journal · doi:10.1007/s10995-005-0005-7 · Cited by 9
Longrois, D., Agavriloaia, M., Devaux, Y., & Mertès, P. (2009) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2009.02.042 · Cited by 9
Psouni, E., Vicente, R. P., Dahlin, L. B., & Merlo, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193635 · Cited by 9
Heine, J., Land, W. H., & Egan, K. M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-37 · Cited by 9
The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries: Response
Krosshaug, T., Steffen, K., Kristianslund, E. K., Nilstad, A., Mok, K.-M., Myklebust, G., Andersen, T. E., Holme, I., Engebretsen, L., & Bahr, R. (2016) · The American Journal of Sports Medicine · doi:10.1177/0363546516651042 · Cited by 9
Waist circumference does not improve established cardiovascular disease risk prediction modeling
Nelms, M. W., Day, A. G., Sui, X., Blair, S. N., & Ross, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240214 · Cited by 8
Immune-Related LncRNAs to Construct a Prognosis Risk-Assessment Model for Gastric Cancer
Zhi, S., Yang, B., Zhou, S., Tan, J., Zhong, G., & Han, F. (2022) · Current Oncology · doi:10.3390/curroncol29070391 · Cited by 8
Advanced colorectal neoplasia risk stratification by penalized logistic regression
Lin, Y., Yu, M., Wang, S., Chappell, R. J., & Imperiale, T. F. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280213497432 · Cited by 8
Hypertension and stable coronary artery disease: an overview
Pedrinelli, R., Ballo, P., Fiorentini, C., Galderisi, M., Ganau, A., Germanò, G., Innelli, P., Paini, A., Perlini, S., Salvetti, M., et al. (2013) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283609332 · Cited by 8
Calculating Probability in Sex Offender Risk Assessment
Elwood, R. W. (2016) · International Journal of Offender Therapy and Comparative Criminology · doi:10.1177/0306624x16677784 · Cited by 8
Busch, E. L., Don, P. K., Chu, H., Richardson, D. B., Keku, T. O., Eberhard, D. A., Avery, C. L., & Sandler, R. S. (2018) · BMC Cancer · doi:10.1186/s12885-017-3964-3 · Cited by 8
Gleiß, A., & SCHEMPER, M. (2019) · Statistics in Medicine · doi:10.1002/sim.8331 · Cited by 8
Galán, I., Rodríguez‐Blázquez, C., Simón, L., Ortíz, C., López‐Cuadrado, T., & Merlo, J. (2021) · Health & Place · doi:10.1016/j.healthplace.2021.102506 · Cited by 8
Multiple step-variable pathway hypothesis: A reason why predictions fail in atherosclerosis
Ferns, G. A. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.014 · Cited by 8
Design aspects for prognostic factor studies
Sekula, P., Steinbrenner, I., Schultheiß, U. T., Valveny, N., Rebora, P., Halabi, S., Cadarette, S. M., Riley, R. D., Collins, G. S., Sauerbrei, W., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-095065 · Cited by 7
Jones, A. S. K., Seaton, N., Brown, A., Jenkinson, E., Carroll, S., Dietz, K. C., Hudson, J. L., Wroe, A. L., & Moss-Morris, R. E. (2025) · Psychological Medicine · doi:10.1017/s003329172500090x · Cited by 7
Goetzinger, K. R., Tuuli, M. G., & Odibo, A. O. (2011) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2011.30.10.1415 · Cited by 7
Serum palmitic acid–oleic acid ratio and the risk of coronary artery disease: a case-control study
Sun, L.-B., Zhang, Y., Wang, Q., Zhang, H., Xu, W., Zhang, J., Xiang, J., Li, Q.-G., Xiang, Y., Wang, D., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.02.009 · Cited by 7
Conde, D., Salvador, B., Rueda, C., & Fernández, M. A. (2013) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/sagmb-2012-0037 · Cited by 7
Brinton, J. T., Hendrick, R. E., Ringham, B. M., Kriege, M., & Glueck, D. H. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01208-9 · Cited by 7
Attwood, K. M., & Tian, L. (2020) · Communication in Statistics- Theory and Methods · doi:10.1080/03610926.2020.1751852 · Cited by 7
Metrics for Evaluating Polygenic Risk Scores
Baker, S. G. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa106 · Cited by 7
Levinson, S. S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.015 · Cited by 7
Park, S. H., Kim, C., Kim, D. J., Cheong, J. Y., Cho, S. W., Hwang, S. G., Lee, Y. J., Cho, M., Yang, J. M., & Kim, Y. B. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1477-x · Cited by 7
Diminished Renal Function and the Incidence of Heart Failure
Ärnlöv, J. (2009) · Current Cardiology Reviews · doi:10.2174/157340309788970388 · Cited by 7
Wang, Y., Koh, W., Yuan, J., & Pan, A. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0216-0 · Cited by 7
Cartus, A. R., Naimi, A. I., Himes, K. P., Jarlenski, M., Parisi, S. M., & Bodnar, L. M. (2021) · Epidemiology · doi:10.1097/ede.0000000000001433 · Cited by 7
Novel serum biomarkers for the prediction of cardiovascular risk
Roberfroid, D., Miguel, L. S., & Thiry, N. (2013) · doi:10.57598/r201c · Cited by 7
Traditional Versus New Models of Risk Prediction
Sehestedt, T. B., & Olsen, M. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801387-8.00021-1 · Cited by 7
Standardizing Markers to Evaluate and Compare their Performances
PEPE, M. S., & Longton, G. (2005) · Collection of Biostatistics Research Archive · Cited by 7
Self-citationLloyd‐Jones, D. M., & Greenland, P. (2004) · Circulation · doi:10.1161/01.cir.0000149807.32506.f4 · Cited by 7
Risk Factors, Risk Prediction, and the Apolipoprotein B–Apolipoprotein A-I Ratio
Berkwits, M., & Güallar, E. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00012 · Cited by 7
Goldberger, J. J., & Hendel, R. C. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004275 · Cited by 7
Pinelli, S., Mandorino, M., Fantozzi, S., & Lacome, M. (2025) · Applied Sciences · doi:10.3390/app15031659 · Cited by 6
Dysmorphology-Based Prediction Model for Genetic Disorders in Infants With Congenital Heart Disease
Helm, B. M., Wetherill, L. F., Landis, B. J., & Ware, S. M. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.124.004895 · Cited by 6
Öberg, J., Khalaf, K., Vicente, R. P., Johnell, K., Fastbom, J., & Merlo, J. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13335-y · Cited by 6
Cui, Y. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106106 · Cited by 6
Utility of Acoustic Pharyngometry for the Diagnosis of Obstructive Sleep Apnea
Kendzerska, T., Grewal, M., & Ryan, C. M. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201601-056oc · Cited by 6
Fasching, P. A., Häberle, L., Rack, B. K., Li, L., Hein, A., Ekici, A. B., Reis, A., Lux, M. P., Cunningham, J. M., Ruebner, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17726 · Cited by 6
Blodgett, J. M., Hardy, R., Davis, D. H. J., Peeters, G. M. E. E., Hamer, M., Kuh, D. J., & Cooper, R. (2023) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2022.1066913 · Cited by 6
Achmad, C., Kamarullah, W., Putra, I. C. S., Firmansyah, D. K., Iqbal, M., Karwiky, G., Pramudyo, M., Martha, J. W., & Akbar, M. R. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101727 · Cited by 6
Requirements of a Good Biomarker: Translation into the Clinical Laboratory
Plebani, M., Zaninotto, M., & Mion, M. M. (2007) · Wiley eBooks · doi:10.1002/9783527622153.ch33 · Cited by 7
Les courbes de poids fœtales et néonatales et la restriction de croissance intra-utérine
Gouyon, J., Ferdynus, C., & Quantin, C. (2013) · Archives de Pédiatrie · doi:10.1016/j.arcped.2013.06.017 · Cited by 6
Ivert, A., Mulinari, S., van Leeuwen, W., Wagner, P., & Merlo, J. (2016) · Ethnicity and Health · doi:10.1080/13557858.2016.1143090 · Cited by 6
Issues in developing multivariable molecular signatures for guiding clinical care decisions
Sachs, M. C., & McShane, L. M. (2016) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2016.1226329 · Cited by 6
Sufficient Dimension Reduction for Censored Predictors
Tomassi, D., Forzani, L., Bura, E., & Pfeiffer, R. M. (2016) · Biometrics · doi:10.1111/biom.12556 · Cited by 6
Demler, O., Paynter, N. P., & Cook, N. R. (2018) · Diagnostic and Prognostic Research · doi:10.1186/s41512-018-0034-5 · Cited by 6
Brittan, M. S., Martin, S., Anderson, L., Moss, A. F. D., & Torok, M. R. (2018) · Journal of Hospital Medicine · doi:10.12788/jhm.3043 · Cited by 6
Bonnesen, K., Heide‐Jørgensen, U., Albertsen, L. W., Schmidt, S. A. J., Sørensen, H. T., & Schmidt, M. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.02.013 · Cited by 6
Assessment of heterogeneous Head Start treatment effects on cognitive and social-emotional outcomes
Lee, S. Y., Kim, R., Rodgers, J., & Subramanian, S. V. (2022) · Scientific Reports · doi:10.1038/s41598-022-10192-1 · Cited by 6
Olsen, M., Fischer, K., Bossuyt, P. M., & Goetghebeur, E. J. T. (2021) · BMC Cancer · doi:10.1186/s12885-021-08937-8 · Cited by 6
Ericsson, L., Wemrell, M., Lindström, M., Vicente, R. P., & Merlo, J. (2022) · Scandinavian Journal of Public Health · doi:10.1177/14034948221112465 · Cited by 6
Evaluating subject-level incremental values of new markers for risk classification rule
Cai, T., Tian, L., Lloyd‐Jones, D. M., & Wei, L. J. (2013) · Lifetime Data Analysis · doi:10.1007/s10985-013-9272-6 · Cited by 6
Challenges in DNA Microarray Studies from the Regulatory Perspective
Lababidi, S. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701668324 · Cited by 6
Uso da proteína C reativa na prevenção da aterosclerose: entre Jupiter e Marte
Miname, M. H., & Santos, R. D. (2009) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302009000500003 · Cited by 6
A reversal coarse‐grained analysis with application to an altered functional circuit in depression
Guo, S., Yu, Y., Zhang, J., & Feng, J. (2013) · Brain and Behavior · doi:10.1002/brb3.173 · Cited by 6
Drug Therapies for the Primary Prevention of Cardiovascular Events: Trials and Errors
Psaty, B. M. (2010) · Circulation · doi:10.1161/circulationaha.109.933705 · Cited by 6
Ojha, R. P., Brown, L., Felini, M., Singh, K. P., & Thertulien, R. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.496881 · Cited by 6
Targeted Local Support Vector Machine for Age-Dependent Classification
Chen, T., Wang, Y., Chen, H., Marder, K. S., & Zeng, D. (2014) · Journal of the American Statistical Association · doi:10.1080/01621459.2014.881743 · Cited by 6
Metadata
- Authors
- Pepe, M. S.
- Affiliations
- Fred Hutch Cancer Center (US)
- Corresponding author
- Pepe, M. S.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 159
- Issue
- 9
- Pages
- 882-890
- ISSN
- 0002-9262 (ISSN-L)
- OpenAlex
- W2121514893
- Cited by
- 1,276
- References
- 27
- Citations by year
- 2026: 56 · 2025: 44 · 2024: 21 · 2023: 35 · 2022: 39 · 2021: 46 · 2020: 46 · 2019: 46 · 2018: 68 · 2017: 63 · 2016: 69 · 2015: 69 · 2014: 72 · 2013: 73 · 2012: 82
- FWCI
- 41.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (U01CA86368, U01CA074794, P01 CA18029, U01CA086368, P01CA018029)
- National Institute of General Medical Sciences (R01 GM 54438, R01GM054438)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- odds ratio, diagnostic biomarkers, prognostic factors, screening marker, receiver operating characteristic, classification accuracy, false positives, true positives, logistic regression, association measures
- MeSH terms
- Classification, Data Interpretation, Statistical, Epidemiologic Methods, False Positive Reactions, Humans, Mass Screening, Predictive Value of Tests, Prognosis, Risk Factors, ROC Curve, Reproducibility of Results, Biomarkers, Discriminant Analysis, Logistic Models, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.